开放获取期刊获得更多读者和引用
700 种期刊 和 15,000,000 名读者 每份期刊 获得 25,000 多名读者
Dr. Matthew Wang
Cancer, a complex and multifactorial disease, continues to be a global health concern. Over the years, researchers have made significant strides in understanding the molecular mechanisms underlying cancer development and progression. Among these mechanisms, the inflammasome pathway has emerged as a fascinating area of investigation. Inflammasomes are multiprotein complexes that play a critical role in the regulation of inflammation and immunity. In recent years, mounting evidence has implicated inflammasomes in cancer, revealing their dual nature as both promoters and suppressors of tumorigenesis. This article aims to delve into the intricate relationship between inflammasomes and cancer, shedding light on their potential as therapeutic targets.